ArticleCellular and molecular gastroenterology and hepatology2019

Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice.

Sohji Nishina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.